Format

Send to

Choose Destination
Expert Opin Ther Targets. 2003 Aug;7(4):523-6.

Gremlin - a putative pathogenic player in progressive renal disease.

Author information

1
Centre for Integrative Biology, Conway Institute of Biomolecular and Biomedical Research, Department of Medicine and Therapeutics, University College Dublin, The Dulin Molecular Medicine Centre, Belfield, Ireland. vincent.dolan@ucd.ie

Abstract

Progressive renal fibrosis is the end process of renal injury leading to kidney failure. Current therapies for chronic renal failure aim to slow this process but fail to halt its progression. As the mechanisms involved in glomerulosclerosis and tubulointerstitial fibrosis are unravelled, potential treatments for this growing clinical problem should emerge. Gremlin, a developmental regulator of bone morphogenetic proteins (BMPs), has recently been implicated in processes such as glomerulosclerosis, tubulointerstitial fibrosis and cellular hypertrophy, and may represent a novel therapeutic target in progressive renal diseases.

PMID:
12885271
DOI:
10.1517/14728222.7.4.523
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center